CHLORHYDRATE DE PYRIDOXINE RENAUDIN 250 mg/5 ml, solution for injection in an ampoule 10 ampoules of 5 ml
Active ingredients: Pyridoxine hydrochloride
Commercialized according to BDPM
Solution for injection10 ampoules of 5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CHLORHYDRATE DE PYRIDOXINE RENAUDIN 250 mg/5 mL, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 ampoule(s) bouteille en verre de 5 ml
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 2007
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68022996CIP73643052CIP133400936430525Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PYRIDOXINE (CHLORHYDRATE DE)solution | 250 mg · 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.